Concepedia

Joel Bergman

JB

9

Publications

930

Citations

9

H-Index

2011

Active since

Affiliations

University of Illinois Chicago(Current)

Moffitt Cancer Center

Johns Hopkins Medicine

Johns Hopkins University

Center for Cancer Research

Joel Bergman is an author at University of Illinois Chicago specializing in medicine, cell biology, and natural sciences.

Top concepts

Publications per year

2011–2017

9

Publications

9

Selective Histone Deacetylase 6 Inhibitors Bearing Substituted Urea Linkers Inhibit Melanoma Cell Growth

Joel Bergman, Karrune Woan, Patricio Perez-Villarroel et al. · Journal of Medicinal Chemistry · 2012 · 188 citations · Full text

, , +20

Divergent roles of histone deacetylase 6 (HDAC6) and histone deacetylase 11 (HDAC11) on the transcriptional regulation of IL10 in antigen presenting cells

Fengdong Cheng, Maritza Lienlaf, Patricio Perez-Villarroel et al. · Molecular Immunology · 2014 · 137 citations · Full text

, , +10

Targeting histone deacetylase 6 mediates a dual anti‐melanoma effect: Enhanced antitumor immunity and impaired cell proliferation

Karrune Woan, Maritza Lienlaf, P. Perez-Villaroel et al. · Molecular Oncology · 2015 · 134 citations · Full text

Histone deacetylase 6 inhibition improves memory and reduces total tau levels in a mouse model of tau deposition

Maj-Linda B. Selenica, Leif Benner, Steven B. Housley et al. · Alzheimer s Research & Therapy · 2014 · 130 citations · Full text

Tubastatin A, an HDAC6 inhibitor, alleviates stroke-induced brain infarction and functional deficits: potential roles of α-tubulin acetylation and FGF-21 up-regulation

Zhifei Wang, Yan Leng, Junyu Wang et al. · Scientific Reports · 2016 · 113 citations · Full text

Rows per page

1–5 of 9